Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Israel Hanin
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Anatomy
Procedures
Disorders
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
12
Wülfert, Ernst
10
Cornelli, Umberto
9
Dudas, Bertalan
8
Lorens, Stanley
8
Lee, John
6
Fareed, Jawed
5
Rose, Michael
5
Ma, Qing
4
Jeske, Walter
3
Hejna, Matthew
3
Hoppensteadt, Debra
3
Mervis, Ronald
3
Linhardt, Robert
2
Walenga, Jeanine
2
Walzer, Mark
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Israel Hanin (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: Hanin Israel; Windisch Manfred; Poewe Werner; Fisher Abraham
The 8th International Conference on Alzheimer's and Parkinson's Diseases. Preface.
Neuro-degenerative diseases 2008;5(3-4):113.
-
2007: Ma Qing; Cornelli Umberto; Hanin Israel; Jeske Walter P; Linhardt Robert J; Walenga Jeanine M; Fareed Jawed; Lee John M
Heparin oligosaccharides as potential therapeutic agents in senile dementia.
Current pharmaceutical design 2007;13(15):1607-16.
-
2007: Ma Qing; Tobu Mahmut; Schultz Christopher; Jeske Walter; Hoppensteadt Debra; Walenga Jeanine; Cornelli Umberto; Lee John; Linhardt Robert; Hanin Israel; Fareed Jawed
Molecular weight dependent tissue factor pathway inhibitor release by heparin and heparin oligosaccharides.
Thrombosis research 2007;119(5):653-61.
-
2005: Semeniken K; Hanin I; Dudas B
Low intracerebroventricular doses of cholinotoxin AF64A do not affect the morphology of gonadotropin hormone-releasing hormone (GnRH)-immunoreactive fibers in the rat septum.
Brain research 2005;1049(2):240-3.
-
2005: Dudas Bertalan; Rose Michael; Cornelli Umberto; Hanin Israel
Low molecular weight glycosaminoglycan C3 attenuates AF64A-stimulated, low-affinity nerve growth factor receptor-immunoreactive axonal varicosities in the rat septum.
Brain research 2005;1033(1):34-40.
-
2004: Rose M; Dudas B; Cornelli U; Hanin I
Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner.
Brain research 2004;1015(1-2):96-102.
-
2004: Dudas Bertalan; Hanin Israel; Rose M; Wülfert Ernst
Protection against inflammatory neurodegeneration and glial cell death by 7beta-hydroxy epiandrosterone, a novel neurosteroid.
Neurobiology of disease 2004;15(2):262-8.
-
2003: Rose M; Dudas B; Cornelli U; Hanin I
Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats.
Neurobiology of aging 2003;24(3):481-90.
-
2003: Dudas Bertalan; Rose Michael; Hanin Israel
Dose-dependent effect of cholinotoxin AF64A on the cholinergic elements of the cingulum bundle in rat.
Brain research 2003;965(1-2):295-8.
-
2003: Ma Qing; Schultz Christopher; Neville Brian; Jeske Walter; Hoppensteadt Debra; Cornelli Umberto; Lee John; Lorens Stanley; Hanin Israel; Fareed Jawed
Pharmacodynamics and pharmacokinetics of C3, a heparin-derived oligosaccharide mixture, in non-human primates.
Thrombosis research 2003;112(4):249-55.
-
2002: Walzer Mark; Lorens Stanley; Hejna Matthew; Fareed Jawed; Hanin Israel; Cornelli Umberto; Lee John M
Low molecular weight glycosaminoglycan blockade of beta-amyloid induced neuropathology.
European journal of pharmacology 2002;445(3):211-20.
-
2002: Ma Qing; Dudas Bertalan; Hejna Matthew; Cornelli Umberto; Lee John M; Lorens Stanley; Mervis Ronald; Hanin Israel; Fareed Jawed
The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3.
Thrombosis research 2002;105(5):447-53.
-
2002: Ma Qing; Dudas Bertalan; Daud Asif; Iqbal Omer; Hoppensteadt Debra; Jeske Walter; Cornelli Umberto; Lee John; Lorens Stanley; Mervis Ronald; Hanin Israel; Capila Ishan; Linhardt Robert; Fareed Jawed
Molecular and biochemical profiling of a heparin-derived oligosaccharide, C3.
Thrombosis research 2002;105(4):303-9.
-
2002: Dudas B; Cornelli U; Lee J M; Hejna M J; Walzer M; Lorens S A; Mervis R F; Fareed J; Hanin I
Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain.
Neurobiology of aging 2002;23(1):97-104.
-
2000: Dudás B; Mihaly A; Hanin I
A ventral approach to stereotaxy of the guinea pig brain.
Journal of neuroscience methods 2000;99(1-2):79-83.
-
1999: Fan Q I; Hanin I
Effects of AF64A on gene expression of choline acetyltransferase (ChAT) in the septo-hippocampal pathway and striatum in vivo.
Neurochemical research 1999;24(1):15-24.
-
1998: Zhang X; Kindel G; Wülfert E; Hanin I
Mivazerol inhibits intrathecal release of glutamate evoked by halothane withdrawal in rats.
Acta anaesthesiologica Scandinavica 1998;42(8):1004-9.
-
1998: Santiago L R; Erickson L C; Hanin I
AF64A-induced changes in N-myc expression in the LA-N-2 human neuroblastoma cell line are modulated by choline and hemicholinium-3.
Neurochemical research 1998;23(5):743-50.
-
1998: Pranzatelli M R; Hanin I; Tate E; Kindel G; Bergin A; Brown C M; Habersang P; Habersang R; Mack K J; Rosenbaum B; Selby K A; Vasconcellos M
Cerebrospinal fluid free choline in movement disorders of paediatric onset.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 1998;2(1):33-9.
-
1997: Kim S Y; Raikoff K; Wülfert E; Hanin I
Bradycardia induced by mivazerol, a selective alpha 2-adrenoceptor agonist, is amplified during mild hypothermia in the pentobarbital-anesthetized rat.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1997;11(6):751-5.
-
1997: Willson C A; Hanin I
Brain-derived neurotrophic factor induced stimulation of septal choline acetyltransferase activity in ethylcholine mustard aziridinium treated rats.
Neuroscience letters 1997;229(3):149-52.
-
1997: Zhang X; Wülfert E; Hanin I
Mivazerol, a new alpha 2-adrenergic agonist, blunts cardiovascular effects following surgical stress in pentobarbital-anesthetized rats.
Acta anaesthesiologica Scandinavica 1997;41(6):694-700.
-
1996: Kim S Y; Raikoff K; Wülfert E; Hanin I
Mivazerol, a selective alpha 2-adrenoceptor agonist, attenuates tachycardia by intrathecal injection of N-methyl-D-aspartate in the rat.
European journal of pharmacology 1996;316(2-3):249-52.
-
1996: El Tamer A; Prokopenko I; Wülfert E; Hanin I
Mivazerol, a novel alpha2-agonist and potential anti-ischemic drug, inhibits KC1-stimulated neurotransmitter release in rat nervous tissue preparations.
Journal of neurochemistry 1996;67(2):636-44.
-
1996: El Tamer A; Wülfert E; Hanin I
Age-dependent effect of AF64A on cholinergic activity in the septo-hippocampal pathway of the rat brain: decreased responsiveness in aged rats.
Neuroscience letters 1996;203(2):123-6.
-
1996: Hanin I
The AF64A model of cholinergic hypofunction: an update.
Life sciences 1996;58(22):1955-64.
-
1995: Zhang X; Kindel G H; Wülfert E; Hanin I
Effects of immobilization stress on hippocampal monoamine release: modification by mivazerol, a new alpha 2-adrenoceptor agonist.
Neuropharmacology 1995;34(12):1661-72.
-
1995: Santiago L R; Ivy M T; Erickson L C; Hanin I
AF64A-induced cytotoxicity and changes in choline acetyltransferase activity in the LA-N-2 neuroblastoma cell line are modulated by choline and hemicholinium-3.
Journal of neuroscience methods 1995;61(1-2):185-90.
-
1995: Willson C A; Hanin I
Effect of nerve growth factor in ethylcholine mustard aziridinium (AF64A)-treated rats: sensitization of cholinergic enzyme activity in the septohippocampal pathway.
Journal of neurochemistry 1995;65(2):856-62.
-
1995: Chrobak J J; Hanin I; Lorens S A; Napier T C
Within-subject decline in delayed-non-match-to-sample radial arm maze performance in aging Sprague-Dawley rats.
Behavioral neuroscience 1995;109(2):241-5.
-
1995: Willson C A; Luthman J; Hoffer B; Hanin I
The use of the rat iris as a model system to evaluate the effect of the cholinotoxin, AF64A, in vivo.
Journal of neuroscience methods 1995;56(1):49-55.
-
1994: Amoroso D; Kindel G; Wülfert E; Hanin I
Long-term exposure to high levels of corticosterone aggravates AF64A-induced cholinergic hypofunction in rat hippocampus in vivo.
Brain research 1994;661(1-2):9-18.
-
1994: Dong X W; Hanin I; Lorens S A
AF64A affects septal choline acetyltransferase but not parvalbumin immunoreactive cells.
Brain research bulletin 1994;35(3):217-20.
-
1993: el Tamer A; Raikoff K; Corey J; Wülfert E; Hanin I
ucb 11056, a new potential nootropic drug, amplifies induced cyclic AMP formation in rat brain tissue.
Journal of neurochemistry 1993;61(6):2256-61.
-
1993: Hanin I; Tang X C; Kindel G L; Kozikowski A P
Natural and synthetic Huperzine A: effect on cholinergic function in vitro and in vivo.
Annals of the New York Academy of Sciences 1993;695():304-6.
-
1993: Elrod K; Raikoff K; Wulfert E; Hanin I
UCB 29120, a novel, potential psychotropic agent, alters norepinephrine and dopamine content of rat brain.
Neuropharmacology 1993;32(6):535-42.
-
1993: Hanin I
Clinical aspects of cholinergic pharmacology.
Progress in brain research 1993;98():421-2.
-
1993: Hörtnagl H; Hansen L; Kindel G; Schneider B; el Tamer A; Hanin I
Sex differences and estrous cycle-variations in the AF64A-induced cholinergic deficit in the rat hippocampus.
Brain research bulletin 1993;31(1-2):129-34.
-
1992: Hanin I
Cholinergic toxins and Alzheimer's disease.
Annals of the New York Academy of Sciences 1992;648():63-70.
-
1992: Futscher B W; Pieper R O; Barnes D M; Hanin I; Erickson L C
DNA-damaging and transcription-terminating lesions induced by AF64A in vitro.
Journal of neurochemistry 1992;58(4):1504-9.
-
1992: el Tamer A; Corey J; Wülfert E; Hanin I
Reversible cholinergic changes induced by AF64A in rat hippocampus and possible septal compensatory effect.
Neuropharmacology 1992;31(4):397-402.
-
1992: Zhang X; Wulfert E; Hanin I
Development of a sensitive and inexpensive micropush-pull technique for the continuous analysis of brain neurotransmitters and metabolites in vivo.
Journal of neuroscience methods 1992;42(1-2):139-47.
-
1991: Laganière S; Corey J; Tang X C; Wülfert E; Hanin I
Acute and chronic studies with the anticholinesterase Huperzine A: effect on central nervous system cholinergic parameters.
Neuropharmacology 1991;30(7):763-8.
-
1991: Lorens S A; Kindel G; Dong X W; Lee J M; Hanin I
Septal choline acetyltransferase immunoreactive neurons: dose-dependent effects of AF64A.
Brain research bulletin 1991;26(6):965-71.
-
1991: Chrobak J J; Napier T C; Hanin I; Walsh T J
The pharmacology of basal forebrain involvement in cognition.
Advances in experimental medicine and biology 1991;295():383-98.
-
1990: Laganiere S; Marinko M; Corey J; Wulfert E; Hanin I
Sector-dependent neurotoxicity of ethylcholine aziridinium (AF64A) in the rat hippocampus.
Neuropharmacology 1990;29(10):961-4.
-
1990: Hanin I
AF64A-induced cholinergic hypofunction.
Progress in brain research 1990;84():289-99.
-
1989: Potter P E; Tedford C E; Kindel G; Hanin I
Inhibition of high affinity choline transport attenuates both cholinergic and non-cholinergic effects of ethylcholine aziridinium (AF64A).
Brain research 1989;487(2):238-44.
-
1989: Hörtnagl H; Potter P E; Singer E A; Kindel G; Hanin I
Clonidine prevents transient loss of noradrenaline in response to cholinergic hypofunction induced by ethylcholine aziridinium (AF64A).
Journal of neurochemistry 1989;52(3):853-8.
-
1989: Hörtnagl H; Potter P E; Kindel G; Hanin I
Noradrenaline depletion protects cholinergic neurons in rat hippocampus against AF64A-induced damage.
Journal of neuroscience methods 1989;27(2):103-8.
-
1988: Hörtnagl H; Potter P E; Happe K; Goldstein S; Leventer S; Wulfert E; Hanin I
Role of the aziridinium moiety in the in vivo cholinotoxicity of ethylcholine aziridinium ion (AF64A).
Journal of neuroscience methods 1988;23(2):107-13.
-
1987: Hörtnagl H; Potter P E; Hanin I
Effect of cholinergic deficit induced by ethylcholine aziridinium (AF64A) on noradrenergic and dopaminergic parameters in rat brain.
Brain research 1987;421(1-2):75-84.
-
1987: Hörtnagl H; Potter P E; Hanin I
Effect of cholinergic deficit induced by ethylcholine aziridinium on serotonergic parameters in rat brain.
Neuroscience 1987;22(1):203-13.
-
1987: Leventer S M; Wulfert E; Hanin I
Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo.
Neuropharmacology 1987;26(4):361-5.
-
1985: Leventer S; McKeag D; Clancy M; Wulfert E; Hanin I
Intracerebroventricular administration of ethylcholine mustard aziridinium ion (AF64A) reduces release of acetylcholine from rat hippocampal slices.
Neuropharmacology 1985;24(5):453-9.
Sign-in to see more
